Press release content from PR Newswire. The AP news staff was not involved in its creation.
Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA
January 27, 2021 GMT
INCHEON, South Korea, Jan. 26, 2021 /PRNewswire/ Samsung Biologics (KRX: 207940.KS) announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy, furthering the company’s track record as a premiere CDO service provider in the global market.
In late 2018, National OncoVenture (NOV), a government-funded virtual oncology drug development program in South Korea, approached Samsung Biologics for the development of EU101(NOV1801), an anti-4-1BB therapeutic monoclonal antibody provided by Eutilex (KOSDAQ:263050). Studied by NOV and Eutilex with humanized mice, EU101(NOV1801), effectively eradicated human tumors and showed synergistic anti-tumor activity with immune checkpoint blockade.
WDR 2 Jetzt Gote: Bratkartoffeln
wdr.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wdr.de Daily Mail and Mail on Sunday newspapers.
Así son las restricciones por el coronavirus en los diferentes países de Europa
antena3.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from antena3.com Daily Mail and Mail on Sunday newspapers.
Samsung Biologics is aiming to become ‘a full-service biopharmaceutical company’: creating a greater global footprint for its CDMO business, continuing to advance its biosimilars business, and laying the groundwork for novel drug development.
Speaking at the 29
th annual JP Morgan Healthcare Conference yesterday, John Rim – who took on the reins as CEO last month – unveiled the South Korean company s growth plans.
In 2021 it will speed up construction of its Plant 4 ‘super plant’, while it is also working to secure manufacturing facilities overseas.
Existing plants nearing capacity
Samsung Biologics work spans across development, manufacturing and laboratory testing services for biopharmaceutical products. In 2020 it signed $1.7bn in CMO contracts – a record-breaking figure – and opening the company’s first overseas CDO R&D center in San Francisco.
Thanksgiving in Spokane and a Black Friday matinee at AMC River Park Square 20 have been a tradition for years for guitarist Al Pitrelli. The musical director of Trans-Siberian Orchestra prefaces the bandâs annual Black Friday night show with some quality time in the Inland Northwest.
âFor the last five or six years, what Iâm accustomed to, and the same goes for the rest of Trans-Siberian Orchestra, is that we celebrate Thanksgiving in Spokane and then we go to the movies the following day before we perform at the Spokane Arena,â Pitrelli said from his Milford, Pennsylvania, home.
âI remember seeing the premiere of the film âCreedâ in Spokane (in 2015), and we go back to that theater every year. I love Spokane, but things are obviously a little different this year.â